OneSource Specialty Pharma Company Description

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally.

The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics.

It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products.

The company was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024.

OneSource Specialty Pharma Limited was incorporated in 2007 and is based in Bengaluru, India.

OneSource Specialty Pharma Limited

Country	India
Founded	2007
Industry	Biotechnology
Sector	Healthcare
Employees	1,412
CEO	Neeraj Sharma

Contact Details

Address: Star 1, Opp IIM Bangalore Bengaluru, Karnataka 560076 India
Phone	91 80 6784 0738
Website	onesourcecdmo.com

Stock Details

Ticker Symbol	ONESOURCE
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE013P01021
SIC Code	8731

Key Executives

Name	Position
Neeraj Sharma	Chief Executive Officer, MD and Director
Anurag Bhagania	Chief Financial Officer
Allada Trisha	Company Secretary and Compliance officer
Arun Kumar Pillai B.Com.	Founder and Non-Executive Director
Biju Mathew	Chief Operating Officer
Dr. Prateek Gupta	Senior Vice President and Head of Technical Development
Milan Doshi	Senior Vice President of Global BD
Ravi Kumar	Head of Corporate Strategy and Operational Excellence
Bernhard Thurnbauer	Chief Quality Officer
Jeffrey Wong	Chief Business Officer